
Doctor Jonathan Wright
The Ohio State University, Columbus (United States of America)
Follow
Contributor content
Journal
Targeting angiogenesis, unmasking coronary risk: incidence, predictors, and outcomes of coronary events with VEGFR tyrosine kinase inhibitors
3 August 2026
Journal
When cancer therapy raises the pressure: predictors of early hypertension with VEGFR inhibitors
3 August 2026


